Another warning letter for Lupin as FDA identifies deficiencies at India-based site
With few new details of what needs fixing, Lupin disclosed last week that the FDA recently sent a warning letter to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
